Srishti Srivastava, MD
Pain Medicine · Coral Gables, FLNPI 1518493469
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $463 of the $763 with a category attached, or 60.7%. Tersera Therapeutics LLC accounts for 63.9% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $434, 3.0 times the $143 reported in 2022. That places this record below the midpoint for pain medicine clinicians in FL, where the typical reported total is $2,085.
Across 24 payments — averaging $31.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tersera Therapeutics LLC$488
- SPR Therapeutics, Inc$117
- AbbVie$59
- Stryker$39
- Boston Scientific$38
- Averitas Pharma Inc.$22
What the payments were for
- Food & beverage$46361%
- Education$30039%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tersera Therapeutics LLC | 15 | $488 |
| SPR Therapeutics, Inc | 1 | $117 |
| AbbVie | 3 | $59 |
| Stryker | 2 | $39 |
| Boston Scientific | 2 | $38 |
| Averitas Pharma Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$763 in reported general payments places this provider in the 30th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 308 | $8,751 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 86 | $3,109 |
| Pregabalin | 119 | $2,876 |
| Gabapentin | 94 | $1,500 |
| Duloxetine Hcl | 115 | $1,262 |
| Cyclobenzaprine Hcl | 69 | $745 |
| Tizanidine Hcl | 38 | $607 |
| Celecoxib | 32 | $475 |
| Tramadol Hcl | 49 | $381 |
| Baclofen | 14 | $183 |
| Oxycodone Hcl | 13 | $151 |
| Nortriptyline Hcl | 16 | $148 |
| Meloxicam | 15 | $120 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Coral Gables
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
- Nicholas BremerFernandina Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.